The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Immunogenicity of protein therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.-C., Lanzavecchia, A., & Manz, M. G. (2004) · Science · doi:10.1126/science.1093933 · Cited by 993
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 985
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Akashi, K., Shultz, L. D., & Harada, M. (2005) · Blood · doi:10.1182/blood-2005-02-0516 · Cited by 932
Bonifaz, L. C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S.-I., Soares, H., Brimnes, M. K., Moltedo, B., Moran, T. M., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032220 · Cited by 921
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., & Taniguchi, T. (2005) · Nature · doi:10.1038/nature03547 · Cited by 912
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., & Moser, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1413 · Cited by 762
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
Immunogenicity of engineered antibodies
Hwang, W. Y. K., & Foote, J. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.001 · Cited by 630
Mire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
Ehrenforth, S., Kreuz, W., Linde, R., Funk, M., Güngor, T., Krackhardt, B., Kornhuber, B., & Scharrer, I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90874-3 · Cited by 605
A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling
Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., & Ravetch, J. V. (1994) · Nature · doi:10.1038/368070a0 · Cited by 580
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Self- and nonself-recognition by C-type lectins on dendritic cells
Geijtenbeek, T. B. H., van Vliet, S. J., Engering, A., 't Hart, B. A., & van Kooyk, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104558 · Cited by 503
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Cytoplasmic Domain Heterogeneity and Functions of IgG Fc Receptors in B Lymphocytes
Amigorena, S., Bonnerot, C., Drake, J. R., Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P., Sautes, C., Mellman, I., & Fridman, W. H. (1992) · Science · doi:10.1126/science.1535455 · Cited by 455
Radstake, T. R. D. J., Svenson, M., Eijsbouts, A. M., van den Hoogen, F. H. J., Enevold, C., van Riel, P. L. C. M., & Bendtzen, K. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092833 · Cited by 377
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
International workshop on immune tolerance induction: consensus recommendations1
DIMICHELE, D. M., HOOTS, W. K., PIPE, S. W., RIVARD, G. E., & SANTAGOSTINO, E. (2007) · Haemophilia · doi:10.1111/j.1365-2516.2007.01497.x · Cited by 278
TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a
Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., & Bachmann, M. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2415 · Cited by 273
Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0318 · Cited by 272
Koren, E., Zuckerman, L., & Mire-Sluis, A. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378175 · Cited by 267
Viral immune evasion: a masterpiece of evolution
Vossen, M. T., Westerhout, E. M., Söderberg-Nauclér, C., & Wiertz, E. J. (2002) · Immunogenetics · doi:10.1007/s00251-002-0493-1 · Cited by 261
Antibody humanization: a case of the ‘Emperor’s new clothes’?
Clark, M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01680-7 · Cited by 258
Boven, K., Stryker, S., Knight, J., Thomas, A., van Regenmortel, M., Kemeny, D. M., Power, D., Rossert, J., & Casadevall, N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00340.x · Cited by 251
Gupta, S., Indelicato, S. R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A. R., Richards, S. M., Rup, B., Shores, E., Swanson, S. J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.004 · Cited by 241
Rosloniec, E. F., Brand, D. D., Myers, L. K., Whittington, K. B., Gumanovskaya, M., Zaller, D. M., Woods, A., Altmann, D. M., Stuart, J. M., & Kang, A. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1113 · Cited by 222
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
Steere, A. C., Klitz, W., Drouin, E. E., Falk, B. A., Kwok, W. W., Nepom, G. T., & Baxter-Lowe, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052471 · Cited by 205
Hermeling, S., Schellekens, H., Maas, C., Gebbink, M. F. B. G., Crommelin, D. J. A., & Jiskoot, W. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20599 · Cited by 185
Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles
Chackerian, B., Lenz, P., Lowy, D. R., & Schiller, J. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6120 · Cited by 181
Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity
Tangri, S., Mothé, B. R., Eisenbraun, J., Sidney, J., Southwood, S., Briggs, K., Zinckgraf, J., Bilsel, P., Newman, M., Chesnut, R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3187 · Cited by 169
Corthay, A., Bäcklund, J., Broddefalk, J., Michaëlsson, E., Goldschmidt, T. J., Kihlberg, J. O., & Holmdahl, R. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199808)28:08<2580::aid-immu2580>3.0.co;2-x · Cited by 166
Shirai, M., Arichi, T., Nishioka, M., Nomura, T., Ikeda, K., Kawanishi, K., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2733 · Cited by 165
Ishioka, G. Y., Fikes, J., Hermanson, G., Livingston, B., Crimi, C., Qin, M., France del Guercio, M., Oseroff, C., Dahlberg, C., Alexander, J., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3915 · Cited by 164
Bertolotto, A., Malucchi, S., Sala, A., Orefice, G., Carrieri, P. B., Capobianco, M., Milano, E., Melis, F., & Giordana, M. T. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.148 · Cited by 163
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
Livingston, B. D., Newman, M. J., Crimi, C., McKinney, D. M., Chesnut, R. W., & Sette, A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00233-x · Cited by 156
Black, K. E., Murray, J. A., & David, C. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5595 · Cited by 153
Galsky, M. D., Eisenberger, M., Moore-Cooper, S., Kelly, W. K., Slovin, S. F., DeLaCruz, A., Lee, Y., Webb, I. J., & Scher, H. I. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0532 · Cited by 145
Hermeling, S., Caetano, L. A., Damen, M. J. A., Slijper, M., Schellekens, H., Crommelin, D. J. A., & Jiskoot, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8177-9 · Cited by 144
Koren, E., Groot, A. S. D., Jawa, V., Beck, K. D., Boone, T., Rivera, D., Li, L., Mytych, D. T., Koscec, M., Weeraratne, D. K., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.544 · Cited by 143
Ritter, G., Cohen, L., Williams, C., Richards, E. C., Old, L. J., & Welt, S. (2001) · PubMed · Cited by 142
Kong, Y. C., Lomo, L. C., Motte, R. W., Giraldo, A. A., Baisch, J., Strauß, G., Hämmerling, G. J., & David, C. S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1167 · Cited by 137
Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies
Fehr, T. H., Bachmann, M. F., Bucher, E. M., Kalinke, U., Padova, F. E. D., Lang, A. B., Hengartner, H., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1785 · Cited by 135
Lei, S., Lei, H., Green, D., Gill, J. C., Conti‐Fine, B. M., & Reding, M. T. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613257 · Cited by 131
Vallabhajosula, S., Goldsmith, S. J., Kostakoğlu, L., Milowsky, M. I., Nanus, D. M., & Bander, N. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0023 · Cited by 130
Morris, M. J., Divgi, C. R., Pandit-Taskar, N. D., Batraki, M., Warren, N., Nacca, A., Smith-Jones, P. M., Schwartz, L. H., Kelly, W. K., Slovin, S. F., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0826 · Cited by 116
Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
Ss, P., & Muhlfelder, T. W. (1997) · PubMed · Cited by 116
Ottesen, J. L., Nilsson, P., Jami, J., Weilguny, D., D�hrkop, M., Bucchini, D., Havelund, S., & Fogh, J. M. (1994) · Diabetologia · doi:10.1007/bf00399790 · Cited by 107
Enhancement of IgG anti‐carrier responses by IgG2 anti‐hapten antibodies in mice
Coulie, P. G., & Snick, J. V. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150810 · Cited by 104
Immunogenicity of biological therapeutics: a hierarchy of concerns.
Rosenberg, A. S. (2003) · PubMed · Cited by 99
Activation of Dendritic Cells by Toll-Like Receptors and C-Type Lectins
Diebold, S. S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_1 · Cited by 99
Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
Barbosa, M. D. F. S., Vielmetter, J., Chu, S. Y., Smith, D. D., & Jacinto, J. M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.017 · Cited by 99
From genome to vaccine—new immunoinformatics tools for vaccine design
Groot, A. S. D., & Berzofsky, J. A. (2004) · Methods · doi:10.1016/j.ymeth.2004.06.004 · Cited by 93
Immunogenicity screening in protein drug development
Walle, I. V., Gansemans, Y., Parren, P. W. H. I., Stas, P., & Lasters, I. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.3.405 · Cited by 87
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.
Wagner, C. L., Schantz, A., Barnathan, E. S., Olson, A., Mascelli, M. A., Ford, J., Damaraju, L. V., Schaible, T., Maini, R. N., & Tcheng, J. E. (2003) · PubMed · Cited by 85
Genetic analysis of host–parasite coevolution in human malaria
Hill, A. V. S., Jepson, A., Plebanski, M., & Gilbert, S. C. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0116 · Cited by 84
The genetic basis of autoantibody production
Reveille, J. D. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.10.012 · Cited by 84
Yeung, V. P., Chang, J., Miller, J., Barnett, C., Stickler, M. M., & Harding, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6658 · Cited by 81
Adams, E. W., Ratner, D. M., Seeberger, P. H., & Hacohen, N. (2008) · ChemBioChem · doi:10.1002/cbic.200700310 · Cited by 80
Man, S., Newberg, M. H., Crotzer, V. L., Luckey, C. J., Williams, N. S., Chen, Y., Huczko, E. L., Ridge, J. P., & Engelhard, V. H. (1995) · International Immunology · doi:10.1093/intimm/7.4.597 · Cited by 79
McMurry, J. A., Gregory, S. H., Moise, L., Rivera, D. S., Buus, S., & Groot, A. S. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.039 · Cited by 78
Expression and role of Fc- and complement-receptors on human dendritic cells
Bajtay, Z., Csomor, E., Sándor, N., & Erdei, A. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.023 · Cited by 74
Giovannoni, G., Барбараш, О. Л., Casset‐Semanaz, F., King, J. O., Metz, L. M., Pardo, G., Simsarian, J., Sørensen, P. S., Stubinski, B., & on behalf of the Rebif® New Formulation Study Group (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508097299 · Cited by 74
Enumerating Antigen-Specific T-Cell Responses in Peripheral Blood
Hobeika, A. C., Morse, M. A., Osada, T., Ghanayem, M., Niedzwiecki, D., Barrier, R. C., Lyerly, H. K., & Clay, T. M. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200501000-00008 · Cited by 72
Klitgaard, J. L., Coljee, V. W., Andersen, P. S., Rasmussen, L. K., Nielsen, L. S., Haurum, J., & Bregenholt, S. (2006) · Journal of Immunology · doi:10.4049/jimmunol.177.6.3782 · Cited by 71
Naive and memory B cells in T-cell-dependent and T-independent responses
Zubler, R. H. (2001) · Springer Seminars in Immunopathology · doi:10.1007/s281-001-8167-7 · Cited by 71
De-immunization of therapeutic proteins by T-cell epitope modification.
Groot, A. S. D., Knopp, P. M., & Martin, W. J. (2005) · PubMed · Cited by 70
Gg, K. (1979) · PubMed · Cited by 69
How many specific B cells are needed to protect against a virus?
Bachmann, M. F., Kündig, T. M., Kalberer, C. P., Hengartner, H., & Zinkernagel, R. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4235 · Cited by 69
Identification and removal of immunogenicity in therapeutic proteins.
Baker, M., & Jones, T. D. (2007) · PubMed · Cited by 68
A Role for Complement in Feedback Enhancement of Antibody Responses by IgG3
de Ståhl, T. D., Dahlström, J., Carroll, M. C., & Heyman, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022232 · Cited by 68
Clinical investigation of the immunogenicity of interferon-alpha 2a.
Ryff, J. ‐. (1997) · PubMed · Cited by 67
Applequist, S. E., Dahlström, J., Jiang, N., Molina, H. D., & Heyman, B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2398 · Cited by 64
Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients
Cook, S. D., Quinless, J. R., Jotkowitz, A., Beaton, P., & the Neutralizing Antibody Study Group* (2001) · Neurology · doi:10.1212/wnl.57.6.1080 · Cited by 62
Jaber, A., & Baker, M. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.10.023 · Cited by 59
Depression of T-cell Epitope Generation by Stabilizing Hen Lysozyme
So, T., Ito, H.-O., Koga, T., Watanabe, S., Ueda, T., & Imoto, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32136 · Cited by 58
Bertolotto, A., Sala, A., Malucchi, S., Marnetto, F., Caldano, M., Sapio, A. D., Capobianco, M., & Gilli, F. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.037259 · Cited by 58
Deimmunization of Monoclonal Antibodies
Jones, T. D., Crompton, L. J., Carr, F. J., & Baker, M. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-554-1_21 · Cited by 56
Adalimumab for the treatment of Crohn’s disease
Bianchi-Porro, G., Cassinotti, A., & Ardizzone, S. (2008) · Biologics · doi:10.2147/btt.s3292 · Cited by 56
Wadhwa, M., Meager, A., Dilger, P., Bird, C., Dolman, C., Das, R. G., & Thorpe, R. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00949.x · Cited by 55
Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease
Nissenson, A. R. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.29264 · Cited by 55
Pan, S., Trejo, T., Hansen, J., Smart, M. K., & David, C. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2925 · Cited by 55
Challenges to the development of antigen-specific breast cancer vaccines
Scanlan, M. J., & Jäger, D. (2001) · Breast Cancer Research · doi:10.1186/bcr278 · Cited by 54
T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses
Fehr, T. H., Naim, H. Y., Bachmann, M. F., Ochsenbein, A. F., Spielhofer, P., Bucher, E. M., Hengartner, H., Billeter, M., & Zinkernagel, R. M. (1998) · Nature Medicine · doi:10.1038/nm0898-945 · Cited by 52
Zamora, E. D., Handisurya, A., Shafti‐Keramat, S., Borchelt, D., Rudow, G. L., Conant, K. E., Cox, C., Troncoso, J. C., & Kirnbauer, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2662 · Cited by 51
Zwickl, C. M. (1991) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(91)90112-h · Cited by 48
Epoetins: differences and their relevance to immunogenicity
Haselbeck, A. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002063 · Cited by 47
Kamaté, C., Lenting, P. J., van den Berg, H. M., & Mutis, T. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02336.x · Cited by 46
Mucosal antigen presentation and the control of tolerance and immunity
Nagler‐Anderson, C., Terhorst, C., Bhan, A. K., & Podolsky, D. K. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01830-5 · Cited by 45
Jones, T. D., Hanlon, M., Smith, B. J., Heise, C. T., Nayee, P. D., Sanders, D. A., Hamilton, A., Sweet, C., Unitt, E., Alexander, G., et al. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2004.24.560 · Cited by 44
Ta, S., Hollingshead, P. G., Sl, P., Chang, R., Martin, L. E., & Oakley, H. (1989) · PubMed · Cited by 42
Cross-talk between Toll-like receptors 5 and 9 on activation of human immune responses
Merlo, A. C., Calcaterra, C., Ménard, S., & Balsari, A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207100 · Cited by 40
Tobery, T. W., Dubey, S. A., Anderson, K., Freed, D. C., Cox, K. S., Lin, J., Prokop, M. T., Sykes, K. J., Mogg, R., Mehrotra, D. V., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.1081 · Cited by 39
Staelens, S. G., Desmet, J., Ngo, T. H., Vauterin, S., Pareyn, I., Barbeaux, P., Rompaey, I. V., Stassen, J., Deckmyn, H., & Vanhoorelbeke, K. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.018 · Cited by 38
von Wussow, P., Hehlmann, R., Hochhaus, T., Jakschies, D., Nolte, K., Prümmer, O., Ansari, H., Hasford, J., Heimpel, H., & Deicher, H. (1994) · Journal of Interferon Research · doi:10.1089/jir.1994.14.217 · Cited by 38
Damschroder, M. M., Widjaja, L., Gill, P. S., Krasnoperov, V. G., Jiang, W., Dall’Acqua, W. F., & Wu, H. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.019 · Cited by 38
Madoiwa, S., Yamauchi, T., Hakamata, Y., Kobayashi, E., Arai, M., Sugo, T., Mimuro, J., & Sakata, Y. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7933.2004.00671.x · Cited by 37
An In Vitro Human Cell-Based Assay to Rank the Relative Immunogenicity of Proteins
Stickler, M. M., Rochanayon, N., Razo, O. J., Mucha, J., Gebel, W., Faravashi, N., Chin, R., Holmes, S., & Harding, F. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfh021 · Cited by 24
Charo, J., Sundbäck, M., Geluk, A., Ottenhoff, T. H. M., & Kiessling, R. W. (2001) · Human Gene Therapy · doi:10.1089/104303401750476285 · Cited by 23
Viral escape from immune recognition: Multiple strategies of adenoviruses
Müllbacher, A. (1992) · Immunology and Cell Biology · doi:10.1038/icb.1992.9 · Cited by 21
Human population-based identification of CD4+ T-cell peptide epitope determinants
Stickler, M. M., Chin, R., Faravashi, N., Gebel, W., Razo, O. J., Rochanayon, N., Power, S., Valdes, A. M., Holmes, S., & Harding, F. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00279-5 · Cited by 17
Induction of Tolerance to Recombinant Therapeutic Proteins
Méritet, J., Maury, C., & Tovey, M. G. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205150 · Cited by 14
Hellendoorn, K., Jones, T., Watkins, J., Baker, M., Hamilton, A., & Carr, F. J. (2004) · Cancer Cell International · doi:10.1186/1475-2867-4-s1-s20 · Cited by 12
Depil, S., Angyalosi, G., Moralès, O., Delacre, M., Delhem, N., François, V., Georges, B., Hammer, J., Maillère, B., Auriault, C., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.11.048 · Cited by 12
Speculations on the immunogenicity of self proteins.
Diamond, B. (2003) · PubMed · Cited by 10
Factor VIII inhibitors: a continuing problem.
Hoyer, L. (1993) · PubMed · Cited by 10
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Development trends for human monoclonal antibody therapeutics
Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,026
Understanding the contribution of synonymous mutations to human disease
Sauna, Z. E., & Kimchi-Sarfaty, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3051 · Cited by 1,022
Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics
Góngora-Benítez, M., Tulla-Puche, J., & Albericio, F. (2014) · Chemical Reviews · doi:10.1021/cr400031z · Cited by 655
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Metadata
- Authors
- De Groot, A. S., & Scott, D. W.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 28
- Issue
- 11
- Pages
- 482-490
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W1976548137
- Cited by
- 545
- References
- 115
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.